From: Administration of nimotuzumab combined with cisplatin plus 5-fluorouracil as induction therapy improves treatment response and tolerance in patients with locally advanced nasopharyngeal carcinoma receiving concurrent radiochemotherapy: a multicenter randomized controlled study
EGFR expression
NPF group (n = 58)
DPF group (n = 60)
CR
PR
SD
PD
P
0–4%
0
1
3
5–24%
4
6
2
25–49%
7
0.033
50–74%
18
8
23
75–100%
9
10
0.015
0.09
\